Contract Manufacturing, General

Aug 01, 2007
BioPharm International
By BioPharm International Editors
Companies need to avoid operating in a manner that is inconsistent with the priorities established in the strategic sourcing decision.
Jul 01, 2007
BioPharm International
The BIO annual meeting in early May had an upbeat tone. Investment capital is flowing into the industry at high levels, resulting in strong demand for contract development services. The funding stream is particularly strong in the US, and that is attracting more European contract manufacturers (CMOs) eager to improve business development here.
Jun 02, 2007
BioPharm International
By BioPharm International Editors
Biologics manufacturing is a technologically complex, highly regulated process. In comparison to small-molecule manufacturing, biologics manufacturing requires far more planning, investment, and skilled personnel and, therefore, can be much riskier. For biotech companies requiring such manufacturing capabilities and experience, partnering with a biologics-focused contract manufacturing organization (CMO) can be a good solution.
Jun 01, 2007
BioPharm International
By BioPharm International Editors
Outsourcing has been a cornerstone of our industry for decades.
May 23, 2007
BioPharm International
By BioPharm International Editors
Eden Biodesign (Liverpool, UK, www.edenbiodesign.com), SAFC (St. Louis, MO, www.sigmaaldrich.com/SAFC/Pharma), Midatech Group (Oxfordshire, OX, www.midatechgroup.com), Cellexus Systems (Cambridgeshire, UK, www.cellexusbiosystems.com), and BioConvergence LLC (Bloomington, IN, www.bioc.us) are sprucing up their product development and services with the construction of new manufacturing facilities.
May 01, 2007
BioPharm International
By BioPharm International Editors
By outsourcing high-end processes that demand advanced analytical and technical skills, biopharm companies are reaping substantial savings.
May 01, 2007
BioPharm International
Venture capital insiders say that the flow of funds into biopharma shouldcontinue, driven by the large amount of money available for investment.
Apr 02, 2007
BioPharm International
By BioPharm International Editors
The contract manufacturer must have sufficient capacity so it can absorb possible surge in demand, and back-up capability in case of a power failure or other event.
Apr 02, 2007
BioPharm International
By BioPharm International Editors
The greatest benefits of outsourcing are realized when a company takes a strategic approach rather than a tactical approach.
Apr 02, 2007
BioPharm International
By BioPharm International Editors
Consider the number of patients, the dose each will receive (and how this dose is calculated), the number of doses per patient, and what overage is needed to allow for vial breakage.
native1_300x100
lorem ipsum